The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Domain antibodies: proteins for therapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Continuous cultures of fused cells secreting antibody of predefined specificity
KÖHLER, G., & MILSTEIN, C. (1975) · Nature · doi:10.1038/256495a0 · Cited by 17,229
Peters, T. (1985) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60065-0 · Cited by 2,181
Marks, J. D., Hoogenboom, H. R., Bonnert, T. P., McCafferty, J., Griffiths, A. D., & Winter, G. (1991) · Journal of Molecular Biology · doi:10.1016/0022-2836(91)90498-u · Cited by 1,603
Ward, E. S., Güssow, D., Griffiths, A. D., Jones, P. T., & Winter, G. (1989) · Nature · doi:10.1038/341544a0 · Cited by 1,003
Isolation of high affinity human antibodies directly from large synthetic repertoires.
Griffiths, A. D., Williams, S. C., Hartley, O., Tomlinson, I. M., Waterhouse, P., Crosby, W. L., Kontermann, R. E., Jones, P. T., Low, N. M., & Allison, T. J. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06626.x · Cited by 962
Self-citationImproving the efficacy of antibody-based cancer therapies
Carter, P. (2001) · Nature Reviews Cancer · doi:10.1038/35101072 · Cited by 833
Selection and identification of single domain antibody fragments from camel heavy‐chain antibodies
Arbabi Ghahroudi, M., Desmyter, A., Wyns, L., Hamers, R., & Muyldermans, S. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01062-4 · Cited by 768
Single‐domain antibody fragments with high conformational stability
Dumoulin, M., Conrath, K., Van Meirhaeghe, A., Meersman, F., Heremans, K., Frenken, L. G. J., Muyldermans, S., Wyns, L., & Matagne, A. (2002) · Protein Science · doi:10.1110/ps.34602 · Cited by 638
Stability engineering of antibody single-chain Fv fragments
Wörn, A., & Plückthun, A. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.4265 · Cited by 616
Tomlinson, I. M., Walter, G., Marks, J. D., Llewelyn, M. B., & Winter, G. (1992) · Journal of Molecular Biology · doi:10.1016/0022-2836(92)90223-7 · Cited by 603
Self-citationPEGylated antibodies and antibody fragments for improved therapy: a review
Chapman, A. P. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00026-1 · Cited by 556
Crystal structure of a camel single-domain VH antibody fragment in complex with lysozyme
Desmyter, A., Transue, T. R., Ghahroudi, M. A., Dao Thi, M.-H., Poortmans, F., Hamers, R., Muyldermans, S., & Wyns, L. (1996) · Nature Structural & Molecular Biology · doi:10.1038/nsb0996-803 · Cited by 522
Selection of phage antibodies by binding affinity
Hawkins, R. E., Russell, S. J., & Winter, G. (1992) · Journal of Molecular Biology · doi:10.1016/0022-2836(92)90639-2 · Cited by 520
Albumin Binding as a General Strategy for Improving the Pharmacokinetics of Proteins
Dennis, M. S., Zhang, M., Meng, Y. G., Kadkhodayan, M., Kirchhofer, D., Combs, D., & Damico, L. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205854200 · Cited by 508
Protein refolding for industrial processes
Clark, E. D. B. (2001) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(00)00200-7 · Cited by 507
Muyldermans, S., Atarhouch, T., Saldanha, J., Barbosa, J. A. R. G., & Hamers, R. (1994) · "Protein Engineering, Design and Selection" · doi:10.1093/protein/7.9.1129 · Cited by 494
Potent enzyme inhibitors derived from dromedary heavy-chain antibodies
Lauwereys, M. (1998) · The EMBO Journal · doi:10.1093/emboj/17.13.3512 · Cited by 490
van der Linden, R. H. J., Frenken, L. G. J., de Geus, B., Harmsen, M. M., Ruuls, R. C., Stok, W., de Ron, L., Wilson, S., Davis, P., & Verrips, C. T. (1999) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(99)00030-8 · Cited by 471
Hoogenboom, H. R., & Winter, G. (1992) · Journal of Molecular Biology · doi:10.1016/0022-2836(92)90894-p · Cited by 429
By–Passing Immunization: Building High Affinity Human Antibodies by Chain Shuffling
Marks, J. D., Griffiths, A. D., Malmqvist, M., Clackson, T. P., Bye, J. M., & Winter, G. (1992) · Nature Biotechnology · doi:10.1038/nbt0792-779 · Cited by 404
Amino acid sequence studies with Bence-Jones proteins.
Hilschmann, N., & Craig, L. C. (1965) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.53.6.1403 · Cited by 383
Hendershot, L., Bole, D., Köhler, G., & Kearney, J. F. (1987) · The Journal of cell biology · doi:10.1083/jcb.104.3.761 · Cited by 340
Biophysical Properties of Human Antibody Variable Domains
Ewert, S., Huber, T., Honegger, A., & Plückthun, A. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)01237-8 · Cited by 330
Els Conrath, K., Lauwereys, M., Wyns, L., & Muyldermans, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007734200 · Cited by 300
Nguyen, V. K., Hamers, R., Wyns, L., & Muyldermans, S. (2000) · The EMBO Journal · doi:10.1093/emboj/19.5.921 · Cited by 299
Frenken, L. G. J., van der Linden, R. H. J., Hermans, P. W. J. J., Bos, J. W., Ruuls, R. C., de Geus, B., & Verrips, C. T. (2000) · Journal of Biotechnology · doi:10.1016/s0168-1656(99)00228-x · Cited by 286
Length distribution of CDRH3 in antibodies
Wu, T. T., Johnson, G., & Kabat, E. A. (1993) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.340160102 · Cited by 284
Proteolytic selection for protein folding using filamentous bacteriophages
Kristensen, P. K., & Winter, G. P. (1998) · Folding and Design · doi:10.1016/s1359-0278(98)00044-3 · Cited by 272
Efficient tumor targeting by single‐domain antibody fragments of camels
Cortez‐Retamozo, V., Lauwereys, M., Hassanzadeh Gh., G., Gobert, M., Conrath, K., Muyldermans, S., De Baetselier, P., & Revets, H. (2002) · International Journal of Cancer · doi:10.1002/ijc.10212 · Cited by 260
Muruganandam, A., Tanha, J., Narang, S., & Stanimirovic, D. (2002) · The FASEB Journal · doi:10.1096/fj.01-0343fje · Cited by 260
Roux, K. H., Greenberg, A. S., Greene, L., Strelets, L., Avila, D., McKinney, E. C., & Flajnik, M. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11804 · Cited by 232
Low, N. M., Holliger, P., & Winter, G. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0406 · Cited by 216
Human Antibody Fragments Specific for Human Blood Group Antigens from a Phage Display Library
Marks, J. D., Ouwehand, W. H., Bye, J. M., Finnern, R., Gorick, B. D., Voak, D., Thorpe, S., Hughes-Jones, N. C., & Winter, G. (1993) · Nature Biotechnology · doi:10.1038/nbt1093-1145 · Cited by 202
Thermal Unfolding of a Llama Antibody Fragment: A Two-State Reversible Process
Pérez, J. M. J., Renisio, J. G., Prompers, J. J., van Platerink, C. J., Cambillau, C., Darbon, H., & Frenken, L. G. J. (2001) · Biochemistry · doi:10.1021/bi0009082 · Cited by 199
Immunomodulation of enzyme function in plants by single-domain antibody fragments
Jobling, S. A., Jarman, C., Teh, M.-M., Holmberg, N., Blake, C., & Verhoeyen, M. E. (2003) · Nature Biotechnology · doi:10.1038/nbt772 · Cited by 186
Biophysical Properties of Camelid VHH Domains Compared to Those of Human VH3 Domains
Ewert, S., Cambillau, C., Conrath, K., & Plückthun, A. (2002) · Biochemistry · doi:10.1021/bi011239a · Cited by 184
Three Camelid VHH Domains in Complex with Porcine Pancreatic α-Amylase
Desmyter, A., Spinelli, S., Payan, F., Lauwereys, M., Wyns, L., Muyldermans, S., & Cambillau, C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202327200 · Cited by 171
Decanniere, K., Desmyter, A., Lauwereys, M., Ghahroudi, M. A., Muyldermans, S., & Wyns, L. (1999) · Structure · doi:10.1016/s0969-2126(99)80049-5 · Cited by 164
Camelid Heavy-Chain Variable Domains Provide Efficient Combining Sites to Haptens
Spinelli, S., Frenken, L. G. J., Hermans, P., Verrips, T., Brown, K., Tegoni, M., & Cambillau, C. (2000) · Biochemistry · doi:10.1021/bi991830w · Cited by 163
Persic, L., Roberts, A., Wilton, J., Cattaneo, A., Bradbury, A., & Hoogenboom, H. R. (1997) · Gene · doi:10.1016/s0378-1119(96)00628-2 · Cited by 162
The production of antibody fragments and antibody fusion proteins by yeasts and filamentous fungi
Joosten, V., Lokman, C., van den Hondel, C. A. M. J. J., & Punt, P. J. (2003) · Microbial Cell Factories · doi:10.1186/1475-2859-2-1 · Cited by 159
‘Camelising’ human antibody fragments: NMR studies on VH domains
Davies, J., & Riechmann, L. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80432-x · Cited by 158
The crystal structure of a llama heavy chain variable domain
Spinelli, S., Frenken, L. A. M., Bourgeois, D., de Ron, L., Bos, W., Verrips, T. C., Anguille, C., Cambillau, C., & TEGONI, M. (1996) · Nature Structural & Molecular Biology · doi:10.1038/nsb0996-752 · Cited by 149
Antibody VH Domains as Small Recognition Units
Davies, J., & Riechmann, L. (1995) · Nature Biotechnology · doi:10.1038/nbt0595-475 · Cited by 140
Hermes, J. D., Parekh, S., Blacklow, S. C., et al. (1989) · Gene · doi:10.1016/0378-1119(89)90148-0 · Cited by 136
Tanha, J., Dubuc, G., Hirama, T., Narang, S. A., & MacKenzie, C. R. (2002) · Journal of Immunological Methods · doi:10.1016/s0022-1759(02)00027-3 · Cited by 124
Decanniere, K., Muyldermans, S., & Wyns, L. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.3839 · Cited by 110
Avian transgenesis: progress towards the promise
IVARIE, R. D. (2002) · Trends in biotechnology · doi:10.1016/s0167-7799(02)00009-4 · Cited by 110
Ewert, S., Honegger, A., & Plückthun, A. (2003) · Biochemistry · doi:10.1021/bi026448p · Cited by 101
Prolonged in Vivo Residence Times of Antibody Fragments Associated with Albumin
Smith, B. J., Popplewell, A. G., Athwal, D., Chapman, A. P., Heywood, S. P., West, S. M., Carrington, B., Nesbitt, A. M., Lawson, A. D. G., Antoniw, P., et al. (2001) · Bioconjugate Chemistry · doi:10.1021/bc010003g · Cited by 93
Affinity selection of a camelized V(H) domain antibody inhibitor of hepatitis C virus NS3 protease
Martin, F., Volpari, C., Steinkühler, C., Dimasi, N., Brunetti, M., Biasiol, G., Altamura, S., Cortese, R., Francesco, R. D., & Sollazzo, M. (1997) · Protein Engineering Design and Selection · doi:10.1093/protein/10.5.607 · Cited by 89
Antibody manufacture in transgenic animals and comparisons with other systems
Houdebine, L. (2002) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(02)00362-2 · Cited by 84
Jirholt, P., Ohlin, M., Borrebaeck, C. A. K., et al. (1998) · Gene · doi:10.1016/s0378-1119(98)00317-5 · Cited by 84
Optimal Design Features of Camelized Human Single-domain Antibody Libraries
Tanha, J., Xu, P., Chen, Z., Ni, F., Kaplan, H. A., Narang, S. A., & MacKenzie, C. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100770200 · Cited by 82
Reiter, Y., Schuck, P., Boyd, L. F., & Plaksin, D. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.2923 · Cited by 79
Riechmann, L. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0373 · Cited by 57
van den Beucken, T., van Neer, N., Sablon, E., Desmet, J., Celis, L., Hoogenboom, H. R., & Hufton, S. E. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4703 · Cited by 55
Large-scale production of VHH antibody fragments by Saccharomyces cerevisiae
Thomassen, Y. E., Meijer, W., Sierkstra, L. N., & Verrips, C. T. (2002) · Enzyme and Microbial Technology · doi:10.1016/s0141-0229(01)00497-5 · Cited by 55
Improved production and function of llama heavy chain antibody fragments by molecular evolution
van der Linden, R. H. J., de Geus, B., Frenken, L. G. J., Peters, H., & Verrips, C. T. (2000) · Journal of Biotechnology · doi:10.1016/s0168-1656(00)00274-1 · Cited by 51
Bender, E., Woof, J. M., Atkin, J. D., Barker, M. D., Bebbington, C. R., & Burton, D. R. (1993) · Human Antibodies · doi:10.3233/hab-1993-4205 · Cited by 50
Synthetic human antibodies and a strategy for protein engineering
Winter, G. P. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00628-0 · Cited by 46
Vranken, W., Tolkatchev, D., Xu, P., Tanha, J., Chen, Z., Narang, S. A., & Ni, F. (2002) · Biochemistry · doi:10.1021/bi012169a · Cited by 44
Davies, J., & Riechmann, L. (1996) · Immunotechnology · doi:10.1016/s1380-2933(96)00045-0 · Cited by 43
Renisio, J., Pérez, J. M. J., Czisch, M., Guenneugues, M., Bornet, O., Frenken, L. G. J., Cambillau, C., & Darbon, H. (2002) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.10096 · Cited by 38
Solution properties ofEscherichia coli-expressed VH domain of anti-neuraminidase antibody NC41
Kortt, A. A., Guthrie, R. E., Hinds, M. G., Power, B. E., Ivancic, N., Caldwell, J. B., GRUEN, L. C., Norton, R. S., & Hudson, P. J. (1995) · Journal of Protein Chemistry · doi:10.1007/bf01980329 · Cited by 26
Cardiolipin Binding a Light Chain from Lupus-Prone Mice,
Pereira, B., Benedict, C. R., Le, A., Shapiro, S. S., & Thiagarajan, P. (1998) · Biochemistry · doi:10.1021/bi972277q · Cited by 24
Voordijk, S., Hansson, T., Hilvert, D., & van Gunsteren, W. F. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.3890 · Cited by 23
Dubnovitsky, A. P., Kravchuk, Z. I., Chumanevich, A. A., et al. (2000) · PubMed · Cited by 17
Partially structured state of the functional VH domain of the mouse anti‐ferritin antibody F11
Martsev, S. P., Dubnovitsky, A. P., Stremovsky, O. A., Chumanevich, A. A., Tsybovsky, Y., Kravchuk, Z. I., & Deyev, S. M. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02696-0 · Cited by 9
Cited by
Engineering novel binding proteins from nonimmunoglobulin domains
Binz, H. K., Amstutz, P., & Plückthun, A. (2005) · Nature Biotechnology · doi:10.1038/nbt1127 · Cited by 676
Antibody fragments: Hope and hype
Nelson, A. L. (2010) · mAbs · doi:10.4161/mabs.2.1.10786 · Cited by 463
Expression of Recombinant Antibodies
Frenzel, A., Hust, M., & Schirrmann, T. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00217 · Cited by 353
Phage display-derived human antibodies in clinical development and therapy
Frenzel, A., Schirrmann, T., & Hust, M. (2016) · mAbs · doi:10.1080/19420862.2016.1212149 · Cited by 346
Bispecific antibodies for cancer therapy: The light at the end of the tunnel?
Chames, P., & Baty, D. (2009) · mAbs · doi:10.4161/mabs.1.6.10015 · Cited by 336
Metadata
- Authors
- Holt, L. J., Herring, C., Jespers, L. S., Woolven, B. P., & Tomlinson, I. M.
- Venue
- Trends in Biotechnology
- Publisher
- Elsevier BV
- Published
- 2003-11
- Volume
- 21
- Issue
- 11
- Pages
- 484-490
- ISSN
- 0167-7799 (ISSN-L)
- OpenAlex
- W2097478805
- Cited by
- 345
- References
- 69
- FWCI
- 1.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.